Know Cancer

or
forgot password

Treatment Response Evaluation in Patients With Gastrointestinal Stromal Tumor Using PET/CT and DW MRI


N/A
N/A
N/A
Open (Enrolling)
Both
Soft Tissue Neoplasms, Gastrointestinal Tract

Thank you

Trial Information

Treatment Response Evaluation in Patients With Gastrointestinal Stromal Tumor Using PET/CT and DW MRI


Inclusion Criteria:



- Metastatic GIST patients suitable for TKI treatment

- GIST patients pursuing preoperative neoadjuvant TKI treatment

Exclusion Criteria:

- Patients with contraindications to MRI and/or TKI treatment. For patients with renal
failure, CT without intravenous contrast will be performed according to clinical
practice.

- Patients who do not sign the consent paper for any reason or do not accept the study
premises or patients who wish to withdraw for any reason during the study

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Mona-Elisabeth Revheim, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Oslo University Hospital, Dept of Nuclear Medicine

Authority:

Norway:National Committee for Medical and Health Research Ethics

Study ID:

REK-2010/2089

NCT ID:

NCT01276483

Start Date:

February 2011

Completion Date:

Related Keywords:

  • Soft Tissue Neoplasms
  • Gastrointestinal Tract
  • GIST
  • Response Monitoring
  • Functional Magnetic Imaging
  • Positron Emission Tomography
  • Computer Tomography
  • Neoplasms
  • Soft Tissue Neoplasms
  • Gastrointestinal Stromal Tumors

Name

Location